Microbicide delivery: formulation technologies and strategies

Purpose of review: The aim of this article is to summarize the latest information on microbicide formulations for prevention of sexual transmission of HIV infection in women. Recent findings: Although early microbicide formulations were conventionally coitally dependent gel products, new technologies are being developed for vaginal delivery of anti-HIV agents. Intravaginal rings for delivery of microbicides, for example, are being developed and evaluated clinically. Safety and acceptability data are available for many microbicide gels and for one microbicide intravaginal ring. Other microbicide formulations in development for once daily or other vaginal administration strategies include films, tablets, and ovules. Various microbicide formulations for rectal administration are also in development. Summary: New microbicide formulations in development are addressing many of the issues with the original gels such as coital dependency, frequency of use, acceptability, compliance, cost, and adaptability to large-scale production. All of these dosage forms are promising options for safe, effective, and acceptable microbicide products.

Pharmacokinetics of UC781-loaded intravaginal ring segments in rabbits: a comparison of polymer matrices

UC781 is a potent and poorly water-soluble nonnucleoside reverse transcriptase inhibitor being investi- gated as a potential microbicide for preventing sexual transmission of HIV-1. This study was designed to evaluate the in vivo release and pharmacokinetics of UC781 delivered from matrix-type intravaginal ring segments in rabbits. Three polymer matrices (polyurethane, ethylene vinyl acetate copolymer, and silicone elastomer) and two drug loadings (5 and 15 mg/segment) were evaluated in at least one of two independent studies for up to 28 days in vivo. Inter-study comparison of in vivo release, vaginal tissue, and plasma concentrations for similar formulations demonstrated good reproducibility of the animal model. Mean estimates for a 28-day in vivo release ranged from 0.35 to 3.17 mg UC781 per segment. Mean proximal vaginal tissue levels (adjacent to the IVR segment) were 8– 410 ng/g and did not change significantly with time for most formulations. Distal vaginal tissue levels of UC781 were 6- to 49-fold lower than proximal tissue levels. Mean UC781 plasma levels were low for all formulations, at 0.09–0.58 ng/mL. All formulations resulted in similar UC781 concentrations in vaginal tissue and plasma, except the low loading polyurethane group which provided significantly lower levels. Loading dependent release and pharmacokinetics were only clearly observed for the polyurethane matrix. Based on these results, intravaginal ring segments loaded with UC781 led to vaginal tissue concen- trations ranging from below to approximately two orders of magnitude higher than UC781’s EC50 under in vitro conditions (2.8 ng/mL), with little influence by polymer matrix or UC781 loading. Moreover, these findings support the use of rabbit vaginal pharmacokinetic studies in preclinical testing of microbicide intravaginal rings.

Sustained Release of the CCR5 Inhibitors CMPD167 and Maraviroc from Vaginal Rings in Rhesus Macaques

Antiretroviral entry inhibitors are now being considered as vaginally administered microbicide candidates for prevention of sexual transmission of human immunodeficiency virus. Previous studies testing the entry inhibitors maraviroc and CMPD167 in aqueous gel formulations showed efficacy in the macaque challenge model, although protection was highly dependent on the time period between initial gel application and subsequent challenge. In this paper, we describe the sustained release of the entry inhibitors maraviroc and CMPD167 from matrix-type silicone elastomer vaginal rings both in vitro and in vivo. Both inhibitors were released continuously over 28 days from rings in vitro, at rates of 100-2500 µg/day. In 28-day pharmacokinetic studies in rhesus macaques, the compounds were measured in the vaginal fluid and vaginal tissue; steady state fluid concentrations were ~106 fold greater than IC50 values for SHIV-162P3 inhibition in macaque lymphocytes in vitro. Plasma concentrations for both compounds were very low. Pretreatment of macaques with Depo-Provera® (DP), as commonly used in macaque challenge studies, was shown to significantly modify the bio-distribution of the inhibitors, but not the overall amount released. Vaginal fluid and tissue concentrations were significantly decreased while plasma levels increased with DP pretreatment. These observations have implications for designing macaque challenge experiments, and also for ring performance during the human female menstrual cycle. Copyright © 2012, American Society for Microbiology. All Rights Reserved.

Modified Silicone Elastomer Vaginal Gels for Sustained Release of Antiretroviral HIV Microbicides

We previously reported nonaqueous silicone elastomer gels (SEGs) for sustained vaginal administration of the CCR5-targeted entry inhibitor maraviroc (MVC). Here, we describe chemically modified SEGs (h-SEGs) in which the hydrophobic cyclomethicone component was partially replaced with relatively hydrophilic silanol-terminated polydimethylsiloxanes (st-PDMS). MVC and emtricitabine (a nucleoside reverse transcriptase inhibitor), both currently under evaluation as topical microbicides to counter sexual transmission of human immunodeficiency virus type 1 (HIV-1), were used as model antiretroviral (ARV) drugs. Gel viscosity and in vitro ARV release were significantly influenced by st-PDMS molecular weight and concentration in the h-SEGs. Unexpectedly, gels prepared with lower molecular weight grades of st-PDMS showed higher viscosities. h-SEGs provided enhanced release over 24 h compared with aqueous hydroxyethylcellulose (HEC) gels, did not modify the pH of simulated vaginal fluid (SVF), and were shown to less cytotoxic than standard HEC vaginal gel. ARV solubility increased as st-PDMS molecular weight decreased (i.e., as percentage hydroxyl content increased), helping to explain the in vitro release trends. Dye ingression and SVF dilution studies confirmed the increased hydrophilicity of the h-SEGs. h-SEGs have potential for use in vaginal drug delivery, particularly for ARV-based HIV-1 microbicides.

Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir

Objectives: Combination microbicide vaginal rings may be more effective than single microbicide rings at reducing/preventing sexual transmission of HIV. Here, we report the preclinical development and macaque pharmacokinetics of matrix-type silicone elastomer vaginal rings containing dapivirine and darunavir.

Methods: Macaque rings containing 25 mg dapivirine, 300 mg darunavir and 100 mg dapivirine, and 300 mg darunavir were manufactured and characterised by differential scanning calorimetry. In vitro release was assessed into isopropanol/water and simulated vaginal fluid. Macaque vaginal fluid and blood serum concentrations for both antiretrovirals were measured during 28-day ring use. Tissue levels were measured on day 28. Ex vivo challenge studies were performed on vaginal fluid samples and IC50 values calculated.

Results: Darunavir caused a concentration-dependent reduction in the dapivirine melting temperature in both solid drug mixes and in the combination ring. In vitro release from rings was dependent on drug loading, the number of drugs present, and the release medium. In macaques, serum concentrations of both microbicides were maintained between 101–102 pg/mL. Vaginal fluid levels ranged between 103–104 ng/g and 104–105 ng/g for dapivirine and darunavir, respectively. Tissue concentrations ranges for each drug were: vagina (1.8×103–3.8×103 ng/g) > cervix (9.4×101–3.9×102 ng/g) > uterus (0–108 ng/g) > rectum (0–40 ng/g). Measured IC50 values were > 2 ng/mL for both compounds.

Conclusions: Based on these results, and in light of recent clinical progress of the 25mg dapivirine ring, a combination vaginal ring containing dapivirine and darunavir is a viable second-generation HIV microbicide candidate.

Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection

Human Immunodeficiency Virus (HIV) is a retrovirus that can result in rare opportunistic infections occurring in humans. The onset of these infections is known as Acquired Immune Deficiency Syndrome (AIDS). Sexual transmission is responsible for the majority of infections 1, resulting in transmission of HIV due to infected semen or vaginal and cervical secretions containing infected lymphocytes. HIV microbicides are formulations of chemical or biological agents that can be applied to the vagina or rectum with the intention of reducing the acquisition of HIV. Tenofovir is an NRTI that is phosphorylated by adenylate kinase to tenofovir diphosphate, which in turn competes with deoxyadeosine 5’-triphosphate for incorporation into newly synthesized HIV DNA. Once incorporated, tenofovir diphosphate results in chain termination, thus inhibiting viral replication. Tenofovir has been formulated into a range of vaginal formulations, such as rings, tablets gels and films. It has been shown to safe and effective in numerous animal models, while demonstrating safety and acceptability in numerous human trials. The most encouraging results came from the CAPRISA 004 clinical trial which demonstrated that a 1% Tenofovir vaginal gel reduced HIV infection by approximately 39%.

A Combination Vaginal Ring Releasing Dapivirine and Darunavir

Background: Combination microbicide vaginal rings, containing two or more antiretrovirals targeting different steps in the HIV replicative process, may be more effective than single microbicide products at preventing sexual transmission of HIV. Here, we report the preclinical development, including in vitro release and macaque pharmacokinetics, of matrix-type silicone elastomer rings containing dapivirine (DPV; an experimental non-nucleoside reverse transcriptase inhibitor) and darunavir (DRV; a marketed protease inhibitor). Methods: Macaque rings containing 25 mg DPV, 300 mg DRV and 100 mg DPV, and 300 mg DRV were manufactured and characterised by differential scanning calorimetry. In vitro release was assessed into isopropanol/water and simulated vaginal fluid. Macaque vaginal fluid and blood serum concentrations for both antiretrovirals were measured during 28-day ring use. Tissue levels were measured on day 28. Ex vivo challenge studies were performed on vaginal fluid samples and IC50 values calculated.
Results: DRV caused a concentration-dependent reduction in the DPV melting temperature in both solid drug mixes and in the combination ring. In vitro release from rings was dependent on drug loading, the number of drugs present, and the release medium. In macaques, serum concentrations of both
microbicides were maintained between 101-102 pg/mL. Vaginal fluid levels
ranged between 103-104 ng/g and 104-105 ng/g for DPV and DRV, respectively. Vaginal tissue concentrations decreased in rank order: vagina
(1.8×103-3.8×103 ng/g) > cervix (9.4×101-3.9×102 ng/g) > uterus (0-108 ng/g) > rectum (0-40 ng/g). Measured IC50 values (HIV-1 BaL) determined from macaque vaginal fluid samples were < 2 ng/mL for both compounds. Conclusions: Based on these results, and in light of the ongoing clinical progress of the 25mg DPV ring, a combination vaginal ring containing DPV and DRV is a viable second-generation HIV microbicide candidate.

A Temperature-Monitoring Vaginal Ring for Measuring Adherence

Background

Product adherence is a pivotal issue in the development of effective vaginal microbicides to reduce sexual transmission of HIV. To date, the six Phase III studies of vaginal gel products have relied primarily on self-reporting of adherence. Accurate and reliable methods for monitoring user adherence to microbicide-releasing vaginal rings have yet to be established.

Methods

A silicone elastomer vaginal ring prototype containing an embedded, miniature temperature logger has been developed and tested in vitro and in cynomolgus macaques for its potential to continuously monitor environmental temperature and accurately determine episodes of ring insertion and removal.

Results

In vitro studies demonstrated that DST nano-T temperature loggers encapsulated in medical grade silicone elastomer were able to accurately and continuously measure environmental temperature. The devices responded quickly to temperature changes despite being embedded in different thickness of silicone elastomer. Prototype vaginal rings measured higher temperatures compared with a subcutaneously implanted device, showed high sensitivity to diurnal fluctuations in vaginal temperature, and accurately detected periods of ring removal when tested in macaques.

Conclusions

Vaginal rings containing embedded temperature loggers may be useful in the assessment of product adherence in late-stage clinical trials.

Prevenção da sida nos ''idosos'' : aproximação à intervenção do Serviço Social. O caso de Cascais

RESUMO: Os dados estatísticos evidenciam uma tendência para o aumento de casos de HIV/SIDA em indivíduos com mais de 50 anos (OMS, 2008) e apontam a transmissão por via sexual como uma das causas das novas infecções nesta faixa etária. A inexistência de um tratamento ou de uma vacina para o HIV/SIDA faz com que a alteração de comportamentos de risco seja ainda o único meio disponível e universal de prevenir a doença, independentemente da faixa etária considerada. Reconhecendo a dimensão social do fenómeno, e a função preventiva e educativa inerente à actividade dos assistentes sociais, constitui-se como principal objectivo deste estudo compreender o papel do Serviço Social na prevenção do HIV /SIDA e dos comportamentos de risco nos idosos frequentadores de centros de convívio e academias. Especificamente pretendemos identificar o entendimento dos assistentes sociais face à SIDA, à sexualidade e aos comportamentos de risco da população idosa; compreender o papel do Serviço Social na prevenção do HIV/SIDA por relação a outros profissionais; identificar que acções de âmbito preventivo são utilizadas e em que nível da prevenção se situa a intervenção dos assistentes sociais e perceber se a mesma contribui para a mudança de comportamentos de risco. Situámos o estudo numa abordagem qualitativa, e seguimos uma estratégia indutiva. Os dados foram recolhidos através de entrevistas semi-estruturadas, aplicadas a oito assistentes sociais que exercem a sua actividade em Centros de Convívio ou Academias Seniores, no concelho de Cascais. Pela análise e interpretação dos discursos das entrevistadas verifica-se que, a maioria, têm conhecimentos acerca da sexualidade dos idosos no geral e nas respectivas instituições. Percepcionam a sexualidade como algo existente nos idosos, embora se tenham identificado, concomitantemente alguns preconceitos, não sendo um assunto comummente abordado nas suas acções quotidianas. O conhecimento que revelam relativamente ao HIV/SIDA e à expressão do problema a nível global ou local tem uma relação muito directa com a existência, ou não, de casos concretos na instituição. Constatámos que as acções preventivas sobre os comportamentos sexuais de risco são feitas por profissionais exteriores à instituição e de outras áreas, como a enfermagem e a psicologia. Face à regularidade e proximidade com os destinatários da intervenção sublinhamos a importância que os assistentes sociais podem ter no âmbito da prevenção primária, promovendo acções que capacitem, eduquem e motivem os idosos para a adopção de comportamentos saudáveis, sendo também condição sine qua non que os profissionais se reposicionem e assumam esse papel investindo na sua qualificação e especialização. ABSTRACT: The statistical data shows that the number of HIV/AIDS cases in individuals over 50 is rising (OMS, 2008), with the sexual transmission being the prime cause of the new infections in this age group. The non-existence of a treatment or a vaccine for HIV/AIDS leads the change in risk behaviors to remain the only available and universal method to prevent the spreading of this disease, regardless of the age group we are considering. Acknowledging the social dimension of the phenomenon and the inherent preventive and educational function of the Social Workers, the main objective of this study is to understand the role of the Social Work in HIV/AIDS prevention and the risk behaviors of the elderly. Specifically we intend to identify the knowledge the social workers have about HIV/AIDS, about the sexuality and risk behaviors of the elderly; understand the role of the social worker in HIV/AIDS prevention by comparison to other professionals; identify which preventive actions are taken in intervention and in which level of prevention the intervention of social workers takes place, and understand if prevention leads to changing the risk behaviors. We based the study in a qualitative approach, and followed an inductive strategy. The data was gathered by semi-structured interviews, applied to eight Social Workers working in Recreational Centers or Seniors Academies in Cascais’ district. By analyzing and interpreting the interviews we see, that the majority, knows about the sexuality of the elderly in general and in their respective institutions. They see sexuality as something that the elderly possess, although we have also identified some prejudices towards it, and it isn’t a theme usually approached in their daily actions. The knowledge that they reveal about HIV/AIDS and the impact of this problem at a global and local level, is directly linked to the existence, or not, of actual cases in the institution they work. We noticed that the preventive actions on sexual risk behaviors are conducted by professionals that don’t belong to the institution and of other areas of expertise, as Nursing and Psychology. Due to the regularity and proximity with whom the intervention is destined to, we emphasize the importance that the social workers may have in primary prevention, promoting actions that enable, educate and encourage the elderly to adopt health promoting behaviors, also being a sine qua non condition the professionals must reposition themselves and take that role investing in their qualification and specialization.

Toxoplasma gondii in experimentally infected Bos taurus and Bos indicus semen and tissues

Dezoito bovinos foram inoculados com Toxoplasma gondii e distribuídos aleatoriamente em três grupos de seis bovinos cada: GI (2,5x10(5) oocistos da cepa P), GII (5,0x10(6) taquizoítos da cepa RH) e GIII (controle). Exames clínicos, sorológicos e parasitêmicos foram realizados. Pesquisas do parasito, por meio da bioprova e pela técnica de Reação em Cadeia pela Polimerase (PCR), foram realizadas no sêmen e em fragmentos de musculatura esquelética, linfonodos, cérebro, retina, baço, fígado, pulmão, testículo, epidídimo e vesícula seminal. Amostras de sangue e sêmen foram colhidas nos dias -2, -1, 1, 3, 5, 7, 14 e, semanalmente, até o 84º dia pós-infecção (DPI). Os bovinos inoculados (GI e GII) apresentaram hipertermia do 3º ao 16º DPI. Anticorpos contra T. gondii foram detectados (IFI) no 5º DPI (1:16), em ambos grupos inoculados (oocistos e taquizoítos), atingindo picos de 1:4096 no 7º DPI. Surtos parasitêmicos ocorreram em todos os bovinos infectados, principalmente do 7º ao 28º DPI, independente da cepa e inóculo utilizados. O bioensaio revelou a presença do parasito em amostras seminais dos bovinos infectados com oocistos (GI) e taquizoítos (GII), em diversas datas experimentais, entre o 7º e 84º DPI. Parasitismo tissular por T. gondii foi diagnosticado por meio da bioprova e pela técnica da PCR, em vários fragmentos de tecidos e/ou órgãos. Os achados sugerem a possibilidade da ocorrência da transmissão sexual do T. gondii na espécie bovina.

Adesão de protozoários ̀a superfície de dispositivos intra-uterinos

Intrauterine devices (IUD) have been used by approximately hundred million of women in the world. IUD are unprescribed to women who have pelvic inflammation disease predisposition which is caused in general by non-treated sexually transmitted diseases (STD). Trichomoniasis, one of the most important vaginal infections, is caused by a flagellated protozoan, Trichomonas vaginalis, transmitted by sexual contact and also asyntomatic women are able to transmit it. The objective of this work was verify by scanning microscopy the adhesion of this protozoan on plastic and metalic IUD surfaces. IUD fragments were added in Diamond medium containing T. vaginalis and after 3 days at 37°C incubation, they were taken out and treated as necessary for scanning microscopy. The analysis showed showed the adhesion of the protozoans on plastic and metalic IUD surfaces. Even though the IUD were not yet directly associated with high incidence of the inflammation pelvic disease, it would become an infection reservoir of potencial pathogenic organisms.

Toxoplasmose experimental em caprinos machos, com ênfaser no sitema reprodutor

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Transmissão intrafamiliar do HTLV: investigação sorológica em familiares de pacientes acompanhados no ambulatório do Núcleo de Medicina Tropical da UFPA

O Vírus Linfotrópico Humano de Células T é um oncoretrovírus responsável por doenças linfoproliferativas, inflamatórias, degenerativas do Sistema Nervoso Central e por algumas alterações imunológicas do ser humano. Embora tenha associações com várias outras patologias, a Paraparesia Espástica Tropical ou Mielopatia Associada ao HTLV (PET/MAH), doença progressiva e incapacitante do Sistema Nervoso, e a Leucemia/Linfoma de Células T do Adulto (LLcTA), doença linfoproliferativa maligna e letal, são os principais agravos consistentemente definidos como provocados pelo HTLV-1. A propagação do vírus acontece de forma silenciosa, especialmente de mãe para filhos e pela via sexual. No Brasil, onde existem regiões de alta prevalência, ainda são escassas informações oficiais sobre essa transmissão. O objetivo do presente trabalho foi determinar a soroprevalência de anticorpos contra o Vírus Linfotrópico Humano de Células T – tipos 1 e 2 (HTLV-1/2) entre familiares de portadores confirmados do vírus, matriculados no ambulatório do Núcleo de Medicina Tropical (NMT), para estudar as características da transmissão do HTLV nos grupos familiares da região metropolitana de Belém do Pará. Foi realizado um estudo transversal, de base ambulatorial, envolvendo 82 pacientes matriculados no NMT e seus respectivos familiares, os quais foram submetidos à pesquisa de anticorpos anti-HTLV-1/2, utilizando-se o teste de ELISA (Ortho Diagnostic System Inc., US), no período entre junho de 2007 e novembro de 2009. A Soroprevalência da infecção pelo HTLV-1/2 foi observada em 40,2 % (33/82) das famílias e 24,0 % (50/208) no total de familiares pesquisados. A transmissão de mãe para filho(a) ocorreu em 23,2 % (19/82) das famílias, com taxas de soropositividade de 22,4 % (17/76) para filhas e 15,2 % (7/46) para filhos (p > 0.05). A transmissão sexual provável ocorreu em 25,6 % (21/82) das famílias e em 42,0 % (21/50) dos casais, com taxas de soropositividade de esposas e maridos de 53,1 % (18/34) e 18,8 % (3/16), respectivamente (p < 0.05). Não houve diferença significativa de soroprevalência entre familiares de portadores sintomáticos e assintomáticos e entre HTLV-1 e HTLV-2. Conclui-se que existe agregação da infecção nas famílias investigadas e que os dados obtidos estão em acordo com os previamente relatados na literatura. Os serviços de atendimento precisam realizar, rotineiramente, a educação dos indivíduos portadores de HTLV e manter ativas as medidas de controle dos comunicantes familiares, para evitar a propagação do vírus principalmente através do contacto sexual e amamentação.

Pesquisa de Toxoplasma gondii (Nicolle & Manceaux, 1909) em sêmen, testículos e epidídimos de gatos (Felis catus) primoinfectados

Pós-graduação em Medicina Veterinária - FCAV

Soroprevalência, isolamento e diagnóstico molecular para leptospirose em bovinos de fazendas de cria e de centrais de receptoras de embrião da região de Bauru- SP: Diagnóstico de leptospirose bovina em Bauru - SP

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)